QUICKLINKS AND VIEW OPITONS
Niacin lowers Lp(a) by an average of 28%
Wednesday, February 08, 2017 12:16 pm Email this article
Extended-release niacin (1500 to 2000 mg per day) lowers levels of Lp(a) by an average of 28% in people starting with higher levels of Lp(a)—starting levels of 92 mg/dL versus 54 mg/dL—according to a study from Russia.
Elevated levels of Lp(a) (above 50 mg/dL) are associated with an increased risk of heart attack and stroke according to the Lipoprotein a Foundation.
Note: I prefer immediate-release niacin to extended-release niacin. In the 1980’s there were reports of some liver problems with extended-release niacin, and earlier studies showing benefits of niacin used immediate-release niacin, not extended-release.
Artemeva NV, Safarova MS, Ezhov MV, Afanasieva OI, Dmitrieva OA, and Pokrovsky SN. Lowering of lipoprotein(a) level under niacin treatment is dependent on apolipoprotein(a) phenotype. Atheroscler Suppl, 2015 May; 18: 53-58.
Author’s Contact Info
N. V. Artemeva
Institute of Clinical Cardiology
Federal State Institution
“Russian Cardiology Research and Production Center” of
Ministry of Health of the Russian Federation
15A, 3d Cherepkovskaya Street
Moscow 121552, Russia
Other articles about niacin
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.